Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/1998
11/18/1998EP0877623A1 Intranasal vaccination against gastrointestinal disease
11/18/1998EP0877621A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders
11/18/1998EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998CN1198931A Kidney-reinforcing Yang strengthening powder
11/17/1998US5837702 4-arylamino-benzopyran and related compounds
11/17/1998US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837497 DNAs encoding mammalian ZPC and uses thereof
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837268 Immunogens; genetic engineering; noncytotoxic; antitumor agents for breast cancer
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050364A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998WO1998050067A2 Use or a secretion vector for fertility control by oral vaccination
11/12/1998WO1998050063A1 Method of treating hyperprolactinemia and prolactinomas
11/12/1998WO1998050042A1 Pregnan-3-ol-20-ones
11/12/1998WO1998050039A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction
11/12/1998WO1998050026A1 Treatment or prevention of menopausal symptoms and osteoporosis
11/12/1998WO1998050016A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/12/1998DE19720761A1 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung Process for the synthesis and secretion of contraceptive suitable proteins or protein fragments by attenuated salmonella or other gram-negative attenuated vaccine strain to produce an oral vaccination
11/12/1998CA2289006A1 Pregnan-3-ol-20-ones
11/12/1998CA2288899A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998CA2288602A1 Use of a secretion vector for fertility control by oral vaccination
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0876815A1 "Drug delivery system for two or more active substances"
11/11/1998EP0876612A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
11/11/1998EP0876610A1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876166A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body
11/11/1998EP0784467B1 Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv
11/11/1998CN1198672A Gel for the local hormonotherapy of vaginal dryness
11/11/1998CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834521 Treatment of progestin mediated maladies; osteoporosis, cancer
11/10/1998US5834469 Endothelin receptor antagonists
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998CA1340122C Modifications of somatotropins for enhanced stability
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998048819A1 Condensation polymer composition for preventing pregnancy
11/05/1998WO1998048786A1 AMINOTETRALINS AS 5-HT1Dα AGONISTS
11/05/1998WO1998048781A1 Controlled release of drugs delivered by sublingual or buccal administration
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998CA2288897A1 Aminotetralins as 5-ht1d.alpha. agonists
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875511A1 Demethylation process for preparing benzo[b]thiophenes
11/04/1998EP0875506A1 Quinoline and quinazoline compounds useful in therapy
11/04/1998EP0874815A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
11/04/1998EP0874628A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
11/04/1998EP0874622A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
11/04/1998EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
11/04/1998CN1198093A Hormone replacement therapy method and hormone dispenser
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830757 Stimulation of Meiosis
11/03/1998US5830686 Gene expression
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830472 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
11/03/1998CA1340112C Supression of cell proliferation by decorin
10/1998
10/30/1998CA2236254A1 Process for preparing benzo¬b|thiophenes
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/28/1998EP0873751A2 Pharmaceutical product for application to uterus mucosa
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873122A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
10/28/1998EP0873121A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
10/28/1998EP0873120A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
10/28/1998EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998CN1197387A Pharmaceutical compsns. of conjugated estrogens and methods for their use
10/28/1998CN1197076A Steroid compounds having contraceptive and anti-osteoporosis activity
10/28/1998CN1196951A Health wine for nourishing marrow and benefitting semen
10/28/1998CN1196930A Drug delivery system for twor or more active substance
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827892 Treatment and prevention of atherosclerosis
10/27/1998US5827887 Biphenyl compounds
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/22/1998WO1998046635A1 GnRH ANTAGONISTS
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/22/1998WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998WO1998046261A1 Vaginal lactobacillus medicant
10/22/1998WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/21/1998EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998EP0872231A1 Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
10/21/1998EP0871667A1 G-protein coupled receptor
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871624A1 Antagonists of gonadotropin releasing hormone
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 557